Latest Heavy metal Stories
CARLSBAD, Calif., Oct. 23, 2012 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it will receive $1.1 million from Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) as its portion of the upfront fees in Alnylam's recently announced collaboration with Genzyme. In addition, Isis has the potential to receive royalty payments and a portion of future milestone payments. Already this year, Isis has earned $2.7 million from Alnylam as a result of Alnylam's licenses...
LOS ANGELES, Oct. 18, 2012 /PRNewswire/ -- The quality of store-bought Halloween costumes seems to decrease every year, while their prices seem to rise. In response, those with the skillset and the will choose to make their own, quality pieces. Whatever fantastic idea a person may have in mind, he or she can turn to Gold Star Tool, top-rate retailer of sewing supplies. Gold Star Tool is the online store of Los Angeles-based Golden Cutting & Sewing Supplies, which boasts tens of...
CARLSBAD, Calif., Oct. 18, 2012 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced NASDAQ has halted trading of the Company's common stock. The U.S. Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee meets today to review the new drug application (NDA) for KYNAMRO(TM) for the treatment of patients with homozygous familial hypercholesterolemia (FH). The NDA was filed in March 2012 with a standard review of 10 months. The...
CARLSBAD, Calif., Oct. 11, 2012 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that Regulus Therapeutics Inc. recently priced its initial public offering of 11,250,000 shares of Regulus common stock at $4.00 per share. Isis purchased $3 million of Regulus common stock at the offering price and remains a significant shareholder with approximately 7 million shares, or 18 percent of Regulus common stock on a fully diluted basis. Isis co-founded Regulus...
POTTSVILLE, Pa., Oct. 10, 2012 /PRNewswire/ -- EXTOL International, a leading provider of business integration software and services, will discuss the benefits and challenges of modernizing e-commerce infrastructures during a presentation at the New England Electronic Commerce Users' Group (NEECOM) Annual Fall Conference. The event will take place October 18, 2012, at the Doubletree Hotel Westborough in Westborough, Mass. Mark Denchy, manager of channel partnerships at EXTOL, joins...
OHK Medical Devices Ltd., manufacturer of the HemaClear® single-use, sterile, exsanguinating tourniquet device, announced today that it has signed an agreement with Surgical Specialties Pty. to introduce HemaClear® to the Australia and New Zealand markets. This announcement comes as the latest step in the Company’s previously announced five year plan to enter the APAC markets. Haifa, Israel (PRWEB) October 09, 2012 OHK Medical Devices Ltd., manufacturer of the HemaClear®...
POTTSVILLE, Pa., Sept. 24, 2012 /PRNewswire/ -- EXTOL International, a leading provider of business integration software and services, today announced its inclusion in Software Magazine's Software 500 ranking of the world's largest software and service providers, now in its 30(th) year. The Software 500 is a revenue-based ranking of the world's largest software and services suppliers, targeting medium to large enterprises, IT professionals, software developers and business...
Inexpensive, super-sensitive device detects even low levels of toxic metals in water, fish When mercury is dumped into rivers and lakes, the toxic heavy metal can end up in the fish we eat and the water we drink. To help protect consumers from the diseases and conditions associated with mercury, researchers at Northwestern University in collaboration with colleagues at Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland, have developed a nanoparticle system that is sensitive...
CARLSBAD, Calif., Sept. 13, 2012 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it has completed the redemption of the entire $162.5 million of 2 5/8% Convertible Subordinated Notes due 2027. The redemption price plus accrued interest was approximately $164 million and was settled in cash using the net proceeds of the Company's August 2012 issuance of $201.25 million aggregate principal amount of 2 ¾ % Convertible Senior Notes due 2019. "We are...
POTTSVILLE, Pa., Sept. 12, 2012 /PRNewswire/ -- EXTOL International, a leading provider of business integration software and services, today announced the addition of Jim Albright to its executive leadership team as director of marketing. In his new role, Albright will drive awareness and outreach programs for both the overall EXTOL brand and its flagship B2B integration solutions. Albright joins EXTOL with more than a decade of marketing experience, primarily with hardware,...
